; (vii) with respect to each covered member identified in clause (vi), whether the covered member was referred after a positive drug test and the source of such referral; and (viii) the number of fatal overdoses and intentional overdoses. (C) An analysis of discernable patterns in fatal and nonfatal overdoses of covered members. (D) A description of existing or anticipated response efforts to fatal and nonfatal overdoses at military bases that have rates of fatal overdoses that exceed the average rate of fatal overdoses in the United States. (E) An assessment of the availability of substance use disorder treatment for covered members. (F) The number of medical facilities of, or affiliated with, the Department of Defense that have opioid treatment programs. (G) A description of punitive measures taken by the Secretary of Defense in response to substance misuse, substance use disorder, or overdose by covered member. (3) Privacy (A) In general Nothing in this subsection shall be construed to authorize the disclosure by the Secretary of Defense of personally identifiable information of covered members or military family members, including anonymized personal information that could be used to identify covered members or military family members. (B) Application of HIPAA In carrying out this subsection, the Secretary of Defense shall take steps to protect the privacy of covered members and military family members pursuant to regulations prescribed under section 264(c) of the Health Insurance Portability and Accountability Act of 1996 ( 42 U.S.C. 1320d–2 note; Public Law 104–191 ). (b) Definitions In this section: (1) The term covered member means a member of the Army, Navy, Air Force, Marine Corps, or Space Force. (2) The term military family member means a family member of a covered member, including— (A) the spouse, parent, dependent, or child of a covered member